ClinVar Miner

Submissions for variant NM_001197104.2(KMT2A):c.10853del (p.Pro3618fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV002789994 SCV003761304 likely pathogenic Wiedemann-Steiner syndrome 2023-01-25 criteria provided, single submitter curation The heterozygous p.Pro3618ArgfsTer5 variant in KMT2A was identified by our study in one individual with short stature, autism, and dysmorphic features. Trio exome analysis showed this variant to be de novo. The p.Pro3618ArgfsTer5 variant in KMT2A has not been previously reported in individuals with Wiedemann-Steiner syndrome. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 3618 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the KM2TA gene is strongly associated to autosomal dominant Wiedemann-Steiner syndrome. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant Wiedemann-Steiner syndrome. ACMG/AMP Criteria applied: PVS1_Strong, PS2_Supporting, PM2_Supporting (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.